4//SEC Filing
MURPHY JAMES R 4
Accession 0001218893-11-000004
CIK 0001418919other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 2:00 PM ET
Size
8.7 KB
Accession
0001218893-11-000004
Insider Transaction Report
Form 4
MURPHY JAMES R
Director
Transactions
- Disposition to Issuer
Restricted Stock Unit
2011-04-05−7,000→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2011-04-05−10,000→ 0 totalExercise: $17.20Exp: 2018-07-01→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2011-04-05−117,168→ 0 total
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger between CPEX Pharmaceuticals, Inc., FCB I Holdings Inc. and FCB I Acquisition Corp. dated January 3, 2011 (the "Merger Agreement"), each share of CPEX common stock was exchanged for $27.25 and each restrcited sotck unit was cancelled in exchange for a cash payment equal to the product of (i) $27.25 and (ii) the total number of shares underlying such restricted stock unit.
- [F2]This option is fully-vested
- [F3]Pursuant to the Merger Agreement, each CPEX stock option was converted into the right to receive an amount in cash equal to the product of $27.25 over the per share exercise price for such option and the total number of shares underlying such option.
Documents
Issuer
CPEX Pharmaceuticals, Inc.
CIK 0001418919
Entity typeother
Related Parties
1- filerCIK 0001218893
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 2:00 PM ET
- Size
- 8.7 KB